DexCom Inc (DXCM) shareholders
Close on Nov 17, 2026Market cap $30.60BP/E 32.3Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 32,504,140 | 8.30% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 28,848,218 | 7.49% | 13G (passive) | Mar 31, 2026 |
| Vanguard Portfolio Management | 19,322,566 | 5.02% | 13G (passive) | Mar 31, 2026 |
| State Street Corporation | 18,917,265 | 5.00% | 13G (passive) | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DXCM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 38,244,137 | 10.25% | $2.58B | −720,234 | 0.04% |
| Vanguard Capital Management LLC | 25,209,752 | 6.76% | $1.70B | +188,791 | 0.04% |
| Vanguard Portfolio Management LLC | 19,656,540 | 5.27% | $1.32B | +436,587 | 0.06% |
| State Street Corp | 18,380,806 | 4.93% | $1.24B | +445,959 | 0.04% |
| Invesco Ltd. | 15,288,133 | 4.10% | $1.03B | +1,615,819 | 0.08% |
| Baillie Gifford & Co | 14,801,590 | 3.97% | $996.89M | −797,935 | 0.90% |
| Geode Capital Management, LLC | 12,426,515 | 3.33% | $834.17M | +79,877 | 0.04% |
| Alliancebernstein L.P. | 11,693,409 | 3.14% | $734.35M | −1,230,235 | 0.24% |
| UBS Asset Management Americas Inc | 11,261,876 | 3.02% | $758.49M | +1,515,702 | 0.14% |
| Wellington Management Group Llp | 8,527,471 | 2.29% | $574.33M | −798,769 | 0.10% |
| Arrowstreet Capital, Limited Partnership | 6,873,273 | 1.84% | $462.91M | +4,328,170 | 0.21% |
| Norges Bank | 6,868,090 | 1.84% | $462.57M | New | 0.05% |
| UBS Group AG | 6,065,779 | 1.63% | $408.53M | +1,715,820 | 0.05% |
| Amundi | 5,603,490 | 1.50% | $377.40M | −729,071 | 0.09% |
| Morgan Stanley | 5,156,282 | 1.38% | $347.28M | +114,238 | 0.02% |
| Ameriprise Financial Inc | 4,820,775 | 1.29% | $324.68M | +579,991 | 0.07% |
| Castle Hook Partners LP | 3,870,342 | 1.04% | $260.67M | +3,068,495 | 1.20% |
| Goldman Sachs Group Inc | 3,758,616 | 1.01% | $253.14M | +714,981 | 0.02% |
| Franklin Resources Inc | 3,595,893 | 0.96% | $242.18M | +988,455 | 0.05% |
| Massachusetts Financial Services Co /Ma/ | 3,560,621 | 0.95% | $240.92M | +1,626,169 | 0.08% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 971 | 387M | 100.0% | 125 / 397 | 344 / 101 | 51M | 33M |
| Q1 2026 | 962 | 372M | 99.8% | 151 / 372 | 328 / 96 | 100M | 51M |
| Q4 2025 | 923 | 376M | 100.0% | 164 / 348 | 313 / 133 | 74M | 66M |
| Q3 2025 | 911 | 371M | 99.5% | 111 / 338 | 345 / 131 | 52M | 49M |
| Q2 2025 | 940 | 368M | 98.7% | 124 / 338 | 351 / 105 | 35M | 32M |
| Q1 2025 | 933 | 365M | 97.9% | 111 / 374 | 312 / 115 | 44M | 32M |
| Q4 2024 | 950 | 361M | 96.9% | 193 / 332 | 334 / 116 | 46M | 47M |
| Q3 2024 | 891 | 365M | 97.8% | 99 / 332 | 355 / 198 | 77M | 61M |
| Q2 2024 | 1,000 | 383M | 100.0% | 111 / 445 | 308 / 133 | 30M | 30M |
| Q1 2024 | 1,032 | 385M | 100.0% | 156 / 402 | 348 / 87 | 31M | 34M |
| Q4 2023 | 975 | 391M | 100.0% | 195 / 326 | 358 / 114 | 60M | 37M |
| Q3 2023 | 904 | 368M | 98.8% | 112 / 348 | 333 / 153 | 34M | 35M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
847 funds held DXCM in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of DXCM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 12,250,468 | 3.28% | $825.07M | 0.04% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 10,000,154 | 2.68% | $673.51M | 0.04% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 8,360,947 | 2.24% | $563.11M | 0.25% | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | 8,191,004 | 2.20% | $551.66M | 0.11% | Jun 30, 2026 |
| Vanguard Health Care Fund | 5,384,037 | 1.44% | $449.30M | 1.18% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 5,313,803 | 1.42% | $357.88M | 0.04% | Jun 30, 2026 |
| Vanguard Growth Index Fund | 4,947,920 | 1.33% | $333.24M | 0.09% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 4,925,127 | 1.32% | $363.18M | 0.04% | May 31, 2026 |
| Vanguard Mid-Cap Growth Index Fund | 2,956,203 | 0.79% | $199.10M | 0.57% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 2,726,052 | 0.73% | $183.60M | 0.45% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 2,491,889 | 0.67% | $207.95M | 0.22% | Jul 31, 2026 |
| iShares Russell Mid-Cap Growth ETF | 2,263,312 | 0.61% | $152.43M | 0.71% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 2,096,151 | 0.56% | $141.18M | 0.04% | Jun 30, 2026 |
| Ab Large Cap Growth Fund Inc | 1,873,549 | 0.50% | $126.18M | 0.55% | Jun 30, 2026 |
| iShares U.S. Medical Devices ETF | 1,806,986 | 0.48% | $121.70M | 4.02% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 464,753 | 0.12% | Nov 10, 2026 |
| Kevin R. Sayer | Executive Chair, Director | 302,214 | 0.08% | Aug 24, 2026 |
| Sadie Stern | EVP Chief People & Culture Off | 119,462 | 0.03% | Nov 10, 2026 |
| Michael Jon Brown | EVP Chief Legal Compliance Off | 96,734 | 0.03% | Nov 10, 2026 |
| Jereme M. Sylvain | EVP, COO & CFO | 145,377 | 0.04% | Nov 10, 2026 |
| Jon Coleman | EVP, Chief Commercial Officer | 95,450 | 0.03% | Jun 5, 2026 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 42,044 | 0.01% | Jan 30, 2025 |
| Euan A. Ashley | Director | 12,731 | 0.00% | Nov 3, 2026 |
| Nicholas Augustinos | Director | 34,868 | 0.01% | Sep 16, 2026 |
| Glenn S. Boehnlein | Director | 5,883 | 0.00% | Sep 10, 2026 |
| Bridgette P. Heller | Director | 29,570 | 0.01% | Aug 13, 2026 |
| Mark G. Foletta | Director | 55,183 | 0.01% | Aug 4, 2026 |
| Albert Frederick Osterloh IV | Director | 8,691 | 0.00% | Jun 1, 2026 |
| Rimma Driscoll | Director | 17,319 | 0.00% | Jun 1, 2026 |
| Renee D. Gala | Director | 12,486 | 0.00% | Jun 1, 2026 |
| Steven R. Altman | Director | 69,232 | 0.02% | Jun 1, 2026 |
| Richard Alexander Collins | Director | 45,767 | 0.01% | Jun 1, 2026 |
| Kyle Malady | Director | 28,242 | 0.01% | Jun 1, 2026 |
| Eric Topol | Director | 380,545 | 0.10% | May 12, 2025 |
| Karen M. Dahut | Director | 17,779 | 0.00% | May 12, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael Jon Brown EVP Chief Legal Compliance Off | Nov 8, 2026 | Tax withholding | −1,451 | $79.41 | $115.22K | 96,734 |
| Jacob Steven Leach President, CEO, and Director | Nov 8, 2026 | Tax withholding | −1,451 | $79.41 | $115.22K | 417,457 |
| Sadie Stern EVP Chief People & Culture Off | Nov 8, 2026 | Tax withholding | −1,451 | $79.41 | $115.22K | 119,462 |
| Jereme M. Sylvain EVP, COO & CFO | Nov 8, 2026 | Tax withholding | −1,451 | $79.41 | $115.22K | 145,377 |
| Euan A. Ashley Director | Oct 30, 2026 | Gift | −2,389 | – | – | 10,342 |
| Sadie Stern EVP Chief People & Culture Off | Oct 27, 2026 | Sale(10b5-1 plan) | −2,565 | $78.62 | $201.66K | 120,913 |
| Michael Jon Brown EVP Chief Legal Compliance Off | Oct 15, 2026 | Sale(10b5-1 plan) | −1,700 | $85.48 | $145.32K | 98,185 |
| Sadie Stern EVP Chief People & Culture Off | Sep 28, 2026 | Sale(10b5-1 plan) | −2,565 | $86.15 | $220.97K | 123,478 |
| Michael Jon Brown EVP Chief Legal Compliance Off | Sep 15, 2026 | Sale(10b5-1 plan) | −1,700 | $84.04 | $142.87K | 99,885 |
| Nicholas Augustinos Director | Sep 15, 2026 | Sale(10b5-1 plan) | −6,539 | $84.04 | $549.54K | 29,293 |
| Nicholas Augustinos Director | Sep 14, 2026 | Sale(10b5-1 plan) | −1,550 | $84.02 | $130.23K | 35,832 |
| Jereme M. Sylvain EVP, Chief Financal Officer | Sep 10, 2026 | Sale(10b5-1 plan) | −3,638 | $83.27 | $302.94K | 146,828 |
| Glenn S. Boehnlein Director | Sep 10, 2026 | Award | +5,841 | – | – | 5,841 |
| Sadie Stern EVP Chief People & Culture Off | Aug 27, 2026 | Sale(10b5-1 plan) | −2,565 | $88.37 | $226.67K | 126,043 |
| Michael Jon Brown EVP Chief Legal Compliance Off | Aug 22, 2026 | Tax withholding | −1,451 | $92.34 | $133.99K | 101,502 |
| Jereme M. Sylvain EVP, Chief Financal Officer | Aug 22, 2026 | Tax withholding | −1,451 | $92.34 | $133.99K | 150,390 |
| Jacob Steven Leach President, CEO, and Director | Aug 22, 2026 | Tax withholding | −1,451 | $92.34 | $133.99K | 418,908 |
| Sadie Stern EVP Chief People & Culture Off | Aug 22, 2026 | Tax withholding | −1,451 | $92.34 | $133.99K | 128,608 |
| Kevin R. Sayer Executive Chair, Director | Aug 20, 2026 | Sale(10b5-1 plan) | −97 | $91.41 | $8.87K | 302,214 |
| Kevin R. Sayer Executive Chair, Director | Aug 20, 2026 | Sale(10b5-1 plan) | −7,351 | $90.78 | $667.32K | 302,311 |
| Kevin R. Sayer Executive Chair, Director | Aug 20, 2026 | Sale(10b5-1 plan) | −19,308 | $89.71 | $1.73M | 309,662 |
| Michael Jon Brown EVP Chief Legal Compliance Off | Aug 14, 2026 | Sale(10b5-1 plan) | −1,700 | $91.93 | $156.28K | 102,953 |
| Nicholas Augustinos Director | Aug 12, 2026 | Gift | −1,075 | – | – | 37,382 |
| Bridgette P. Heller Director | Aug 12, 2026 | Sale(10b5-1 plan) | −1,012 | $88.29 | $89.35K | 29,570 |
| Mark G. Foletta Director | Aug 3, 2026 | Sale(10b5-1 plan) | −2,000 | $85.32 | $170.64K | 48,852 |
| Mark G. Foletta Director | Jul 31, 2026 | Sale(10b5-1 plan) | −2,000 | $80.00 | $160.00K | 50,852 |
| Kevin R. Sayer Executive Chair, Director | Jul 20, 2026 | Sale(10b5-1 plan) | −26,756 | $76.32 | $2.04M | 328,970 |
| Michael Jon Brown EVP Chief Legal Compliance Off | Jul 15, 2026 | Sale(10b5-1 plan) | −1,700 | $74.42 | $126.51K | 104,653 |
| Kevin R. Sayer Executive Chair, Director | Jul 6, 2026 | Sale(10b5-1 plan) | −26,756 | $72.00 | $1.93M | 355,726 |
| Michael Jon Brown EVP Chief Legal Compliance Off | Jun 15, 2026 | Sale(10b5-1 plan) | −1,700 | $75.55 | $128.44K | 106,353 |
| Mark G. Foletta Director | Jun 15, 2026 | Sale(10b5-1 plan) | −3,801 | $74.10 | $281.65K | 53,051 |
| Mark G. Foletta Director | Jun 15, 2026 | Sale(10b5-1 plan) | −199 | $74.82 | $14.89K | 52,852 |
| Jon Coleman EVP, Chief Commercial Officer | Jun 4, 2026 | Sale(10b5-1 plan) | −4,911 | $74.13 | $364.05K | 95,450 |
| Jon Coleman EVP, Chief Commercial Officer | Jun 3, 2026 | Sale(10b5-1 plan) | −4,912 | $73.00 | $358.58K | 100,361 |
| Steven R. Altman Director | May 28, 2026 | Award | +5,565 | – | – | 5,565 |
| Albert Frederick Osterloh IV Director | May 28, 2026 | Award | +1,630 | – | – | 8,691 |
| Richard Alexander Collins Director | May 28, 2026 | Award | +5,605 | – | – | 5,605 |
| Rimma Driscoll Director | May 28, 2026 | Award | +5,605 | – | – | 17,319 |
| Kyle Malady Director | May 28, 2026 | Award | +5,575 | – | – | 28,242 |
| Euan A. Ashley Director | May 28, 2026 | Award | +5,565 | – | – | 12,731 |
| Nicholas Augustinos Director | May 28, 2026 | Award | +5,575 | – | – | 5,575 |
| Bridgette P. Heller Director | May 28, 2026 | Award | +5,575 | – | – | 30,582 |
| Renee D. Gala Director | May 28, 2026 | Award | +5,605 | – | – | 12,486 |
| Mark G. Foletta Director | May 28, 2026 | Award | +6,331 | – | – | 6,331 |
| Jereme M. Sylvain EVP, Chief Financal Officer | May 22, 2026 | Tax withholding | −1,451 | $71.90 | $104.33K | 151,841 |
| Sadie Stern EVP Chief People & Culture Off | May 22, 2026 | Tax withholding | −1,451 | $71.90 | $104.33K | 130,059 |
| Jacob Steven Leach President, CEO, and Director | May 22, 2026 | Tax withholding | −1,451 | $71.90 | $104.33K | 420,359 |
| Jon Coleman EVP, Chief Commercial Officer | May 22, 2026 | Tax withholding | −7,362 | $71.90 | $529.33K | 105,273 |
| Michael Jon Brown EVP Chief Legal Compliance Off | May 22, 2026 | Tax withholding | −1,451 | $71.90 | $104.33K | 108,053 |
| Kevin R. Sayer Executive Chair, Director | May 21, 2026 | Sale(10b5-1 plan) | −26,759 | $72.00 | $1.93M | 382,482 |
| Michael Jon Brown EVP, Chief Legal Officer | May 15, 2026 | Sale(10b5-1 plan) | −1,700 | $59.91 | $101.85K | 109,504 |
| Bridgette P. Heller Director | May 12, 2026 | Sale(10b5-1 plan) | −1,012 | $60.01 | $60.73K | 25,007 |
| Steven R. Altman Director | May 8, 2026 | Gift | +5,037 | – | – | 63,667 |
| Steven R. Altman Director | May 8, 2026 | Gift | −5,037 | – | – | 0 |
| Nicholas Augustinos Director | May 8, 2026 | Gift | −5,046 | – | – | 0 |
| Nicholas Augustinos Director | May 8, 2026 | Gift | +5,046 | – | – | 38,457 |
| Mark G. Foletta Director | May 8, 2026 | Gift | −5,731 | – | – | 0 |
| Mark G. Foletta Director | May 8, 2026 | Gift | +5,731 | – | – | 56,852 |
| Richard Alexander Collins Director | May 8, 2026 | Gift | +5,074 | – | – | 40,162 |
| Richard Alexander Collins Director | May 8, 2026 | Gift | −5,074 | – | – | 0 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of DexCom's stock actually held short. Settlement fails (shares not delivered on time) peaked at 109,008 shares on Sep 22, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Sadie Stern Officer | Oct 27, 2026 | 2,565 | $201.66K | Oct 27, 2026 | Restricted Stock |
| Michael Jon Brown Officer | Oct 15, 2026 | 1,700 | $145.32K | Oct 15, 2026 | Restricted Stock |
| Sadie Stern Officer | Sep 28, 2026 | 2,565 | $220.97K | Sep 28, 2026 | Restricted Stock |
| Michael Jon Brown Officer | Sep 15, 2026 | 1,700 | $142.87K | Sep 15, 2026 | Restricted Stock |
| Nicholas Augustinos Director | Sep 15, 2026 | 6,539 | $549.54K | Sep 15, 2026 | Vested RSU Grant |
| Nicholas Augustinos Director | Sep 14, 2026 | 1,550 | $130.23K | Sep 14, 2026 | Vested RSU Grant |
| Jereme M. Sylvain Officer | Sep 10, 2026 | 3,638 | $302.94K | Sep 10, 2026 | Restricted Stock |
| Sadie Stern Officer | Aug 27, 2026 | 2,565 | $226.67K | Aug 27, 2026 | Restricted Stock |
| Kevin R. Sayer Officer, Director | Aug 20, 2026 | 26,756 | $2.41M | Aug 20, 2026 | Restricted Stock |
| Michael Jon Brown Officer | Aug 14, 2026 | 1,700 | $156.28K | Aug 14, 2026 | Restricted Stock |
| Bridgette P. Heller Director | Aug 12, 2026 | 1,012 | $89.35K | Aug 12, 2026 | Restricted Stock Vesting |
| Mark G. Foletta Director | Aug 3, 2026 | 2,000 | $170.64K | Aug 3, 2026 | Vested RSUs |
| Mark G. Foletta Director | Jul 31, 2026 | 2,000 | $160.00K | Jul 31, 2026 | Vested RSUs |
| Kevin R. Sayer Officer, Director | Jul 20, 2026 | 26,756 | $2.04M | Jul 20, 2026 | Performance and Restricted Stock |
| Michael Jon Brown Officer | Jul 15, 2026 | 1,700 | $126.51K | Jul 15, 2026 | Restricted Stock |
Congress trades
34 trades in DexCom reported by 12 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Michael T. McCaul TX10 · spouse | Bought | Sep 22, 2025 | $1K–15K | Oct 10, 2025 |
| Michael T. McCaul TX10 · spouse | Bought | Jun 16, 2025 | $1K–15K | Jul 7, 2025 |
| Michael T. McCaul TX10 · spouse | Bought | Jun 9, 2025 | $15K–50K | Jul 7, 2025 |
| Rob Bresnahan PA08 | Bought | May 15, 2025 | $1K–15K | Jun 9, 2025 |
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $15K–50K | Jun 22, 2025 |
| Jefferson Shreve IN06 | Bought | May 8, 2025 | $15K–50K | Jun 22, 2025 |
| Rob Bresnahan PA08 | Sold | Apr 8, 2025 | $1K–15K | Apr 28, 2025 |
| Jefferson Shreve IN06 | Sold | Apr 7, 2025 | $15K–50K | May 8, 2025 |
| Michael T. McCaul TX10 · spouse | Bought | Mar 13, 2025 | $15K–50K | Apr 17, 2025 |
| Rob Bresnahan PA08 | Bought | Feb 25, 2025 | $1K–15K | Mar 27, 2025 |
| Kevin Hern OK01 · joint account | Sold | Dec 31, 2024 | $50K–100K | Jan 15, 2025 |
| Rohit Khanna CA17 · child | Bought | Sep 9, 2024 | $1K–15K | Oct 4, 2024 |
| Josh Gottheimer NJ05 · joint account | Sold | Sep 12, 2023 | $1K–15K | Oct 15, 2023 |
| Rohit Khanna CA17 · child | Bought | Aug 25, 2023 | $1K–15K | Sep 15, 2021 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Aug 21, 2023 | $1K–15K | Sep 16, 2023 |
| Rohit Khanna CA17 · child | Bought | Mar 31, 2023 | $1K–15K | Apr 7, 2022 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Sep 28, 2022 | $1K–15K | Oct 16, 2022 |
| Kevin Hern OK01 · joint account | Bought | Jul 1, 2021 | $100K | Sep 15, 2021 76 days late |
| Thomas Suozzi NY03 | Sold | Jun 3, 2021 | $15K | Sep 23, 2021 112 days late |
| Peter Meijer MI03 | Sold | Feb 16, 2021 | $1K–15K | Mar 16, 2021 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Dec 24, 2020 | $1K–15K | Jan 7, 2021 |
| Gilbert Cisneros CA31 | Sold | Dec 22, 2020 | $1K–15K | Jan 11, 2021 |
| Susie Lee NV03 · joint account | Sold | Oct 2, 2020 | $1K–15K | Dec 8, 2020 67 days late |
| Gilbert Cisneros CA31 | Bought | Sep 16, 2020 | $1K–15K | Oct 14, 2020 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Aug 13, 2020 | $1K–15K | Sep 20, 2020 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | May 11, 2020 | $1K–15K | Jun 10, 2020 |
| Thomas Suozzi NY03 | Bought | Jan 10, 2020 | $1K–15K | Sep 23, 2021 622 days late |
| Thomas Suozzi NY03 | Bought | Jan 9, 2020 | $15K | Sep 23, 2021 623 days late |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Jul 16, 2019 | $1K–15K | Sep 16, 2019 62 days late |
| Bradley S. Schneider IL10 · spouse | Sold | Jun 20, 2019 | $100K | Jun 21, 2019 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Jun 13, 2019 | $1K–15K | Jul 18, 2019 |
| Bradley S. Schneider IL10 · spouse | Bought | Jun 20, 2017 | $100K | Jul 15, 2018 390 days late |
| Josh Gottheimer NJ05 · joint account | Bought | Jan 13, 2017 | $1K–15K | Aug 13, 2018 577 days late |
| Thomas MacArthur NJ03 · joint account | Sold | May 27, 2015 | $1K–15K | Jun 7, 2015 |
See a number that looks wrong?